NAPRT Antibodies

Santa Cruz Biotechnology features a diverse variety of NAPRT monoclonal antibodies for research focused on nicotinate adenine dinucleotide phosphate (NADP) biosynthesis. NAPRT monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nicotinate adenine dinucleotide phosphate (NAPRT) plays a crucial role in the synthesis of NADP, which is essential for various cellular processes, including energy metabolism and antioxidant defense. The regulation of NAPRT is vital for maintaining cellular homeostasis and responding to oxidative stress. Understanding NAPRT function can provide insights into metabolic disorders and potential therapeutic targets. NAPRT research has revealed significant implications for cellular health and disease progression. Current studies focusing on NAPRT have uncovered its importance in metabolic pathways and cellular defense mechanisms. Researchers worldwide rely on Santa Cruz Biotechnology monoclonal antibodies to advance scientific understanding of NAPRT and its role in human health and disease.